Industry Symposia

2:45 PM – 3:30 PM Bio-Rad

Can a droplet change a patient’s cancer treatment? ddPCR Industry Workshop

2:45 PM – 3:30 PM Invivoscribe, Inc.

NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies

2:45 PM – 3:30 PM NanoString Technologies

Validation of antibody panels for high-plex protein analysis on the GeoMx Digital Spatial Profiler

3:30 PM – 3:45 PM Break
3:45 PM – 4:30 PM BGI Americas

Advancement in precision cancer diagnostics for targeted and immunotherapies

3:45 PM – 4:30 PM Illumina, Inc.

How to further drive precision oncology by Comprehensive Genomic Profiling?

3:45 PM – 4:30 PM QIAGEN

Deconstructing the complexity: Tailored sample to insight tools that put your data into action

12:00 PM – 12:45 PM Invivoscribe, Inc.

Monitoring Minimal Residual Disease (MRD) and Somatic Hypermutation (SHM) to Optimize Treatment of Hematologic Malignancies

12:00 PM – 12:45 PM Molecular Health

Scaling the anlyses and interpretation of NGS data with the medical device MH Guide in a clinical setting

12:00 PM – 12:45 PM Thermo Fisher Scientific

Powering Precision Oncology Through Next-Generation Sequencing

10:45 AM – 11:30 AM SOPHiA GENETICS

Making Data Driven Medicine a reality: high precision in routine diagnostics using SOPHiA AI

10:45 AM – 11:30 AM SenseCare Medicals, Inc., USA, A Subsidiary of Urit, China

A Revolutionary Technology to Solve FFPE Sample Preparation Bottle-Neck Problem in Cancer Research and Diagnosis

10:45 AM – 11:30 AM AstraZeneca

East Meets West: Molecular testing in NSCLC to guide patient selection for targeted and immunotherapeutic agents (Sharing of regional molecular practices)

Please note that the information included in this table is preliminary.